BUSINESS/FINANCIAL DESK
| July 12,
2002, Friday Bristol-Myers Under Inquiry On Incentives for Drug Sales
By MELODY
PETERSEN (NYT) 752 words
Late Edition -
Final, Section C, Page 2, Column 5
ABSTRACT
- Securities and
Exchange Commission is investigating whether Bristol-Myers Squibb
overstated revenue in 2001 by giving wholesalers incentives to buy
extraordinary amounts of company's prescription drugs; company says
it is cooperating fully (M)
You can purchase this article:
As a single article for $2.95
As part of an Article 4 Pack for $ 7.95 - A 33% savings.
As part of an Article 10 Pack for $15.95 - A 46% savings.
As part of an Article 25 Pack for $25.95 - A 65% savings.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
